• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BORCS6 参与 Lrrk2 敲除小鼠肺部板层小体的增大。

BORCS6 is involved in the enlargement of lung lamellar bodies in Lrrk2 knockout mice.

机构信息

Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.

Social Cooperation Program of Brain and Neurological Disorders, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.

出版信息

Hum Mol Genet. 2021 Aug 12;30(17):1618-1631. doi: 10.1093/hmg/ddab146.

DOI:10.1093/hmg/ddab146
PMID:34077533
Abstract

Leucine-rich repeat kinase 2 (LRRK2) has been implicated in the pathogenesis of Parkinson disease. It has been shown that Lrrk2 knockout (KO) rodents have enlarged lamellar bodies (LBs) in their alveolar epithelial type II cells, although the underlying mechanisms remain unclear. Here we performed proteomic analyses on LBs isolated from Lrrk2 KO mice and found that the LB proteome is substantially different in Lrrk2 KO mice compared with wild-type mice. In Lrrk2 KO LBs, several Rab proteins were increased, and subunit proteins of BLOC-1-related complex (BORC) were decreased. The amount of surfactant protein C was significantly decreased in the bronchoalveolar lavage fluid obtained from Lrrk2 KO mice, suggesting that LB exocytosis is impaired in Lrrk2 KO mice. We also found that the enlargement of LBs is recapitulated in A549 cells upon KO of LRRK2 or by treating cells with LRRK2 inhibitors. Using this model, we show that KO of BORCS6, a BORC subunit gene, but not other BORC genes, causes LB enlargement. Our findings implicate the LRRK2-BORCS6 pathway in the maintenance of LB morphology.

摘要

富含亮氨酸重复激酶 2(LRRK2)与帕金森病的发病机制有关。已经表明, Lrrk2 敲除(KO)啮齿动物的肺泡上皮 II 型细胞中的板层小体(LB)增大,尽管其潜在机制尚不清楚。在这里,我们对 Lrrk2 KO 小鼠分离的 LB 进行了蛋白质组学分析,发现与野生型小鼠相比,LRRK2 KO 小鼠的 LB 蛋白质组有很大的不同。在 Lrrk2 KO LB 中,几种 Rab 蛋白增加,BLOC-1 相关复合物(BORC)的亚基蛋白减少。从 Lrrk2 KO 小鼠的支气管肺泡灌洗液中获得的表面活性蛋白 C 的量显着减少,表明 Lrrk2 KO 小鼠的 LB 胞吐作用受损。我们还发现,在 A549 细胞中敲除 LRRK2 或用 LRRK2 抑制剂处理细胞后,LB 会增大。使用该模型,我们表明 BORCS6(BORC 亚基基因)的 KO 而不是其他 BORC 基因的 KO 导致 LB 增大。我们的发现表明 LRRK2-BORCS6 途径在维持 LB 形态中起作用。

相似文献

1
BORCS6 is involved in the enlargement of lung lamellar bodies in Lrrk2 knockout mice.BORCS6 参与 Lrrk2 敲除小鼠肺部板层小体的增大。
Hum Mol Genet. 2021 Aug 12;30(17):1618-1631. doi: 10.1093/hmg/ddab146.
2
Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis.LRRK2 敲除大鼠的表面活性剂分泌:板层小体形态和胞吐率的变化。
PLoS One. 2014 Jan 21;9(1):e84926. doi: 10.1371/journal.pone.0084926. eCollection 2014.
3
An in vitro alveolar epithelial cell model recapitulates LRRK2 inhibitor-induced increases in lamellar body size observed in preclinical models.体外肺泡上皮细胞模型再现了临床前模型中观察到的 LRRK2 抑制剂诱导的板层小体大小增加。
Toxicol In Vitro. 2021 Feb;70:105012. doi: 10.1016/j.tiv.2020.105012. Epub 2020 Oct 10.
4
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.LRRK2 蛋白水平由激酶功能决定,对小鼠的肾脏和肺部稳态至关重要。
Hum Mol Genet. 2011 Nov 1;20(21):4209-23. doi: 10.1093/hmg/ddr348. Epub 2011 Aug 9.
5
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung.选择性 LRRK2 激酶抑制对非人类灵长类动物肺的影响。
Sci Transl Med. 2015 Feb 4;7(273):273ra15. doi: 10.1126/scitranslmed.aaa3634.
6
Characterization of the Onset, Progression, and Reversibility of Morphological Changes in Mouse Lung after Pharmacological Inhibition of Leucine-Rich Kinase 2 Kinase Activity.药理学抑制富含亮氨酸激酶2激酶活性后小鼠肺脏形态学变化的起始、进展及可逆性特征
J Pharmacol Exp Ther. 2021 Apr;377(1):11-19. doi: 10.1124/jpet.120.000217. Epub 2021 Jan 28.
7
Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.分析具有路易体病理的 G2019S LRRK2 帕金森病大脑中的巨自噬相关蛋白。
Brain Res. 2018 Dec 15;1701:75-84. doi: 10.1016/j.brainres.2018.07.023. Epub 2018 Jul 25.
8
Early-Onset albuminuria and Associated Renal Pathology in Leucine-Rich Repeat Kinase 2 Knockout Rats.富亮氨酸重复激酶 2 基因敲除大鼠的早期白蛋白尿及相关肾脏病理改变。
Toxicol Pathol. 2023 Jan;51(1-2):15-26. doi: 10.1177/01926233231162809. Epub 2023 Apr 20.
9
LRRK2 is involved in heat exposure-induced acute lung injury and alveolar type II epithelial cell dysfunction.LRRK2 参与热暴露诱导的急性肺损伤和肺泡 II 型上皮细胞功能障碍。
Environ Pollut. 2024 Apr 15;347:123643. doi: 10.1016/j.envpol.2024.123643. Epub 2024 Feb 28.
10
Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice.蛋白质组学分析揭示 LRRK2 敲除小鼠中蛋白质合成和降解途径的协同改变。
Hum Mol Genet. 2018 Sep 15;27(18):3257-3271. doi: 10.1093/hmg/ddy232.

引用本文的文献

1
SLC34A2 inhibits tumorigenesis and progression via upregulating LRRK2/TTF-1/SELENBP1 axis in lung adenocarcinoma.SLC34A2通过上调肺腺癌中的LRRK2/TTF-1/SELENBP1轴来抑制肿瘤发生和进展。
Cancer Gene Ther. 2025 Jul 2. doi: 10.1038/s41417-025-00928-2.
2
Soluble form of Lingo2, an autism spectrum disorder-associated molecule, functions as an excitatory synapse organizer in neurons.Lingo2 的可溶性形式是一种与自闭症谱系障碍相关的分子,它在神经元中作为兴奋性突触的组织者发挥作用。
Transl Psychiatry. 2024 Oct 23;14(1):448. doi: 10.1038/s41398-024-03167-5.
3
GCN5L1 regulates pulmonary surfactant production by modulating lamellar body biogenesis and trafficking in mouse alveolar epithelial cells.
GCN5L1 通过调节小鼠肺泡上皮细胞的板层小体发生和转运来调节肺表面活性剂的产生。
Cell Mol Biol Lett. 2023 Nov 7;28(1):90. doi: 10.1186/s11658-023-00506-0.
4
ADAMTS4 is involved in the production of the Alzheimer disease amyloid biomarker APP669-711.ADAMTS4 参与阿尔茨海默病淀粉样蛋白生物标志物 APP669-711 的产生。
Mol Psychiatry. 2023 Apr;28(4):1802-1812. doi: 10.1038/s41380-023-01946-y. Epub 2023 Feb 1.
5
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects.长期抑制突变型LRRK2的高激酶活性可降低小鼠脑内α-突触核蛋白寡聚体水平,且无不良影响。
NPJ Parkinsons Dis. 2022 Sep 10;8(1):115. doi: 10.1038/s41531-022-00386-9.
6
The emerging role of LRRK2 in tauopathies.LRRK2 在 tau 病中的新兴作用。
Clin Sci (Lond). 2022 Jul 15;136(13):1071-1079. doi: 10.1042/CS20220067.